🇺🇸 FDA
Patent

US 12398179

Nanomolar peptides and derivatives to differentially modulate ephrin receptors

granted A61KA61K38/00A61K38/08

Quick answer

US patent 12398179 (Nanomolar peptides and derivatives to differentially modulate ephrin receptors) held by SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE expires Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE
Grant date
Tue Aug 26 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 21 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K38/00, A61K38/08, A61K38/10, A61K47/56